| Name | Title | Contact Details |
|---|
To build relationships with our Members, Providers, and Partners that strengthen the delivery of healthcare in our community and promotes access to quality healthcare for children, families, and individuals.
More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.
Cell Science Systems Limited Corp is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Deerfield Beach, FL. To find more information about Cell Science Systems Limited Corp, please visit www.alcat.com
Olean General Hospital/Bradford Regional Medical Center is a healthcare provider offering primary and specialty care to residents in southwestern New York state and northwestern Pennsylvania.
EverestLabs is a company that uses AI, robotics, and automation to help material recovery facilities (MRFs) operate more efficiently and enabling CPG brands to exceed their recycled content, EPR and ESG goals.